Analgesia, An International Journal
Larger Image

Analgesia, An International Journal : (changed to Reviews in Analgesia as of Volume 7)

Editor: Robert B. Raffa, Ph.D.

ISSN: 1071-569X

Online

Browse All Subjects and Titles

Aims & Scope

Analgesia is an international journal published four times a year that provides for the rapid review and publication in English of original research reports and reviews involving rigorous ethical experimental studies on the basic mechanisms and therapeutics of pain relief. Preclinical studies will be considered that are directed toward any aspect of pain pathways (e.g., anatomical, biochemical, molecular, pharmacological, or physiological) and their identification; that involve the study of neurotransmitters or modulators; or that investigate some aspect of known or experimental analgesic/antinociceptive compounds (including side effects). Clinical studies will be considered that help elucidate the mechanism of action of known analgesic drugs or that report on the use of combinations. Novel methodological, statistical, theoretical, or mathematical approaches will also be considered.

Volume 6, Numbers 1-4

Volume 5, Numbers 1-4, 2000

Volume 4, Numbers 1-4, 1999

EDITORIAL BOARD

EDITOR-IN-CHIEF

Robert B. Raffa, Ph.D.
Temple University
School of Pharmacy
Philadelphia, PA 19140, USA
EDITORIAL OFFICE ADDRESS
Temple University, School of Pharmacy
3307 North Broad Street
Philadelphia, PA 19140 USA
Phone: 215-707-5227; Fax: 215-707-5228
ADMINISTRATIVE EDITOR
Jeanne E. Coughlin
EDITORIAL BOARD

Keith Budd, Dept. of Anesthetics, Royal Infirmary, Duckworth Lane, Bradford BD9 6RJ, UK
Geoffrey D. Clarke, SmithKline Beecham Consumer Healthcare, Research & Development, St. George's Ave., Weybridge, Surrey, KT13 ODE, UK
Stephen A. Cooper, Whithall Robbins, Inc., Five Giralda Farms, Madison, NJ 17940 USA
Alan Cowan, Dept. of Pharmacology, Temple Univ. School of Medicine, 3420 N. Broad St., Philadelphia, PA 19140-5014 USA
Javier Garzón, Neuropharmacology, Dept. of Neuroanatomy and Cellular Biology, Dr Arce 37, E-28002 Madrid, Spain
Raymond G. Hill, Merck Sharpe and Dohme, Res. Lab/Neuroscience Center, Terlings Park Eastwick Road, Essex CM20 2QR, UK
John C. Hunter, Schering Plough, 2015 Galloping Hil Road, Kenilworth, NJ, 07033 USA
Henry I. Jacoby, Discovery Research, 4119 Ocean Avenue, Brigantine, NJ 08203 USA
Donald R. Jasinski, Center for Chemical Dependence, Johns Hopkins Bayview Medical Ctr., 4940 Eastern Ave., MFL Bldg. 1403, Baltimore, MD 21224-2780 USA
Edward S. Kimball, The R. W. Johnson Pharmaceutical Research Institute, Welsh & McKean Roads, Spring House, PA 19477-0076 USA
Mark J. Millan, Dept. of Neurobiology, Fondax Group de Recherche, 7 Rue Ampere, Puteaux, France
Gavril W. Pasternak, Dept. of Neurology, Memorial Sloan Kettering Cancer Ctr., 1275 York Ave., New York, NY 10021-6007 USA
Sandra C. Roerig, Dept. of Pharmacology, LSU Medical Center, 1501 Kings Highway, Shreveport, LA 71130-3932 USA
Richard B. Rothman, Clinical Psychopharmacology Section, NIDA Addition Research Center, 4940 Eastern Ave., Bldg. C, Baltimore, MD 21224-2735 USA
William K. Schmidt, Adolor Corp., 395 Phoenixville Pike, Malvern, PA 19355 USA
Ronald J. Tallarida, Dept. of Pharmacology, Temple Univ. School of Medicine, 3420 N. Broad Street, Philadelphia, PA 19140-5104 USA
Joseph G. Wettstein, Institut de Recherche Joveinal, 3-9 Rue de al Loge, Fresnes, Cedex, France 94265
James H. Woods, Dept. of Pharmacology, Univ. of Michigan Medical School, 1301 Medical Science Research Bldg. III, Ann Arbor, MI 48109-0632 USA

Authos & Subject Indexes
(Volumes 4-6)

VOLUME 6

Author Index

Adler, M. W., 7
Aloisi, A. M., 19

Benamar, K., 7
Bianchi, M., 39
Bodnar, R. J., 499

Carriere, J., 11
Cavallaro, K., 19
Ceccarelli, I., 19
Connolly, G., 3 

Ferrario, P., 39 

Geller, E. B., 7
Gould, III, H. J., 513
Gould, T. N., 513

 Jain, N. K., 27

Koski, D. M., 11
Krcmery, S., 43
Kulkarni, S. K., 27

Martinez, R. P., 1
Masar, O., 43
Miletic, V., 507
Minor, L., 513

Panerai, A. E., 39
Patil, C. S., 27
Paul, D., 513

 Raffa, R. B., 1, 47
Robins, S., 11

Scarmuzzino, A., 19
Schulingkamp, R. J., 47
Shane, R., 499
Shih, A., 507
Singh, A., 27
Smith, L. J., 507
Stamschror, S., 11

Wiertelak, E. P., 11
Wolkin, J., 499

Xin, L., 7

Subject Index

ACh, 19
Adenosine, 43
Amygdala, 499
Analgesia, 43, 499
Analgesic effectiveness, 3
Animal pain models, 3
Antinociception, 7, 27, 43

Behavior, 19

Carrageenan, 513
Caudal blockade, 43
Central nervous system, 39
cGMP, 27
Chronic constriction injury model, 507
Companion animals, 3

Delta receptor, 499
Delta-opioid antinociception, 1

 Ethical considerations, 3

Gabapentin, 513

Hyperalgesia, 11, 507, 513

Inflammation, 513

Kappa receptor, 499

Lidocaine, 507
Lipopolysaccharide, 11
Lithium, 1
Lithium chloride, 11

M1 metabolite, 39
Morphine, 7
Mu receptor, 499
 

 L-NAME, 27
Neuropathic pain, 507
Nimesulide, 27
Nitric oxide, 7, 27
N-Nitro-L-arginine methyl ester, 7

ORL-1/KOR-3 receptor, 499
Orphanin FQ/nociceptin, 499

Pain, 19, 513
Pain assessment, 3
Periaqueductal gray, 7
Phosphatidylinositol, 1
Plantar test, 19

Rat, 19
Rat plasma, 39

Thalidomide, 11
Tramadol, 39

 

VOLUME 5, 2000

Author Index

Aguilera, C., 63
Arendt-Nielsen, L., 53

Basinski, A., 31
Berger, E., 9
Bhalla, A. P., 35
Bobyntsev, I. I., 223
Bozyk, W., 31
Brandt, M. R., 239

Capurso, U., 13
Coeli, S. M. C. M., 49

Del Ángel, R., 67
Dobrogowski, J., 217
Dureja, G. P., 35

Elzo J, J., 63
Enggaard, T. P., 53

Felip, M., 61
Fuchs, P. N., 1

Gimeno, E. B., 61
Golec, A., 217
Gram, L. F., 53
Gumulka, S. W., 75

 Hu, S., 229

Isanta, M. R., 61

Jain, N. K., 211
Jayalakshmi, T. S., 35

Kolaric, S., 75
Konrad, H., 49
Kulkarni, S. K., 211

Labuz, D., 217
López, E. T., 67
Liu, X. J., 19
Long, K., 229
Lyashev, Y. D., 223

Makulska-Nowak, H. E., 75
Marini, I., 13
Matsutani, K., 39
McCary, J. D., 83
McCleane, G. J., 45
Meyer, R. A., 1

Negus, S. S., 239

 Pellicer, F., 67
Plotnikov, D. V., 223
Poulsen, L., 53
Przewlocka, B., 217

Rabah, E., 63
Raffa, R. B., 83
Raja, S. N., 1

Sawynok, J., 19
Schulingkamp, R. J., 83
Severyanova, L. A., 223
Sindrup, S. H., 53
Singh, A., 211
Smigielska, E., 31
Sotelo, J. C., 61
Souyet, H., 63
Suchorzewski, M., 31

Tsuruoka, M., 39

Vecchiet, F., 13

Xing, J., 229

Xu, H., 229

Yang, H., 229

Subject Index

Adenosine A1 receptor, 19
Adenosine deaminase, 19
Adenosine kinase, 19
Adrenosensitivity, 229
Anticonvulsant, 45
Antihyperalgesia, 19
Antinociception, 211, 239
Antinociceptive effect, 217
Autoreceptor theory, 75

cAMP-dependent protein kinase, 229
Capsaicin, 1
Celiac plexus block, 31
Chronic postoperative pain, 9
Coeruleotrigeminal antinociception, 39
Complex regional pain syndrome, 49
Complications, 31
Cyclooxygenase-1 enzyme, 211
Cyclooxygenase-2 enzyme, 211

Dorsal root ganglion, 229
Dysesthetic neuropathic pain, 61

Electric stimulation, 67
Epibatidine, 239
Experimental pain, 53

Fosphenytoin, 45

b-Funaltrexamine, 75
Ganglion impar, 63
Ganglion of Walther, 63
Glossopharyngeal neuralgia, 35

 Human, 53

Imipramine, 53
Inflammation, 67
Lamotrigine, 61

Locus coeruleus, 39
Lumbar spine surgery, 9

Monkey, 239
Morphine, 239
Multimodality treatment regime, 35
Myofacial trigger points, 13

Naltrindole, 75
Neurolytic block, 63
Neuropathic pain, 1, 19, 45, 49
Neuropeptide effects, 223
Nicotine, 239
Nitric oxide synthesis, 223
NMDA receptor antagonists, 217

Pain, 67
Pain-induced aggression, 223
Pain sensitivity, 223
Paracetamol, 217
Paradoxical analgesia, 75
Paradoxical hypertension, 75
Paroxetine, 53
Perineural fibrosis, 9
Phenytoin, 45
Preferential COX-2 inhibitors, 211
Prostaglandin E2, 239

 Radiation proctitis, 63
Rat, 67
Regional anesthesia, 31

Schedule-controlled responding, 239
Selective COX-2 inhibitors, 211
Self-injury behavior, 67
Spontaneous activity, 229
Sympathetic block, 63
Sympathetically maintained pain, 49
Sympathetically mediated pain, 63

Temporomandibular disorders, 13
Temporomandibular joint, 39
Temporomandibular joint dysfunction, 13
Thalamus, 67
Therapeutic treatment, 1
Thermal hypersensitivity, 239
Transcutaneous electrical nerve stimulation, 35

Visual analog scale, 61

Whiplash injury, 13
Work reintegration, 9
Writhing test, 217

 

VOLUME 4, 1999

Author Index

Bertini, R., 181
Bjorkman, D. J., 483
Busch, T., 187

Carroll, F. I., 27
Caselli, G., 181
Codd, E. E., 173

Del Angel, R., 475

Fendrick, A. M., 483

Gumulka, S. W., 9

Han, S..-M., 461
Hauser, W. A., 483
Heaton, A. H., 483
Hernández-Matheus, D., 405
Hwang, J.-H., 461

Jasinski, D. R., 19
Johnson, R. E., 19
Jones, H. E., 19

 Katz, W. A., 483
Ko, M. C. H., 397
Kolaric, S., 9
Komiyama, T., 467
Koros, E., 9
Kubota, R., 467

Lee, C., 461
Lee, D.-M., 461
Li, Y., 187
López-Avila, A., 475

Makulska-Nowak, H. E., 9
Manning, D. C., 483
Maszczynska, I., 9
McCary, J. D., 197, 409, 505
McCleane, G., 479
Miranda, H. F., 1
Miwa, Y., 467
Molino, L. J., 173
Morgan, G. J., 483

Park, P.-H., 461
Partilla, J. S., 27
Patrick, C. A., 397
Pelissier, T., 1
Pellicer, F., 475
Pinardi, G., 1
Porter, G. A., 483

 Raffa, R. B., 33, 173, 197, 409, 483, 505
Rice, K. C., 27
Roerig, S. C., 187
Rogers, K. E., 173
Rothman, R. B., 27

Shadiack, A. M., 173
Shank, R. P., 173
Shibuya, N., 467
Singh, G., 483
Sotres-Bayón, F., 475

Thomas, J. B., 27
Tortorici, V., 405
Toyoda, H., 467

Vásquez, E., 405
Vanegas, H., 405

Weiner, D. K., 377
Wild, K. D., 33, 173, 197, 409
Woods, J. H., 397

Yagel, S. K., 173

Zimmerman, D. M., 27

Subject Index

Abuse liability, 19
Abuse potential, 19
Allodynia, 173
Allodynic interaction, 461
Analgesia, 173
Anticonvulsant(s), 173, 479
Antinociception, 1, 187, 397
Assessment tools, 377
Autotomy, 475

Buprenorphine, 467
BW942C, 19

Carrageenan, 475
Central sensitization, 405
Chronic pain, 9, 483
Chung model, 173
Clonidine, 187
Cyclooxygenase enzyme system, 181
Cytokine modulation, 181

Denervation, 475
Descending pain inhibitory pathways, 9
Dipyrone, 405
Drug approaches, 483

Economics, 483
Enkephalin, 19
Epidural, 467

 Formalin response, 405
Fosphenytoin, 479

GTP, 27

Hypertension, 9

Inflammation, 475

Kappa opioids, 397
Ketoprofen, 181

Ligand binding, 27

MK-801, 461
Morphine, 9, 19, 187

Naloxonazine, 1
Naloxone, 9
Neostigmine, 461
Nerve ligation injury, 461
Neuropathic pain, 173, 479
Niltrindole, 1
Nociception, 475
Non-drug approaches, 483
Nor-binaltorphimine, 1
NSAIDS, 483

 Older adults, 377
Ondansetron, 1
Opioid(s), 19, 483
Opioid antagonists, 27
Opioid receptors, 27

Pain, 483
Pain assessment, 377
Pentapeptide, 19
Periaqueductal gray, 405
Persistent pain, 377
Pharmacokinetic, 467
Postoperative analgesia, 467
Preemptive analgesia, 467

Rat, 475

Sex difference, 397
Somatic pain, 397
Spinal, 187
Spinal neurons, 405
Subjective effects, 19

Tolerance, 187
Topiramate, 173
Tramadol, 1, 483

Visceral pain, 397

Writhing test, 1

Yohimbine, 1

Volume 6, Number 4
Volume 6, Numbers 1-3

Volume 5, Numbers 3/4
Volume 5, Number 2, 2000
Volume 5, Number 1, 2000

Volume 4, Numbers 1-4, 1999

Full text articles available: CLICK HERE>

Back issues of this journal are available online. Order here>